Clinical trial
Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary…
NCT00390585 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00390585 |
|---|---|
| Title | Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) |
| Official title | Prospective, Randomized, Comparative Study to Evaluate the Effect of Iodixanol 320 Compared to Iomeprol 350 on Contrast Medium Induced Nephropathy in Patients With Impaired Renal Function Undergoing PCI |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Insufficiency, Chronic, Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Iodixanol 320, Iomeprol 350 |
| Enrollment | 324 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Oct 20, 2006 |
| Last update posted | Mar 15, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: